Clinical Trials
6 trialsNCT03426891 2025-10-06
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT03458455 2023-11-01
TREATMENT
Oslo University Hospital
Unknown
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT04291092 2021-09-10
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed